Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: nationwide surveillance from 2003 to 2008 in Japan.

doi:10.1016/j.antiviral.2010.07.008

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: nationwide surveillance from 2003 to 2008 in Japan.

Antiviral research - 1 Oct 2010

Hattori Junko, Shiino Teiichiro, Gatanaga Hiroyuki, Yoshida Shigeru, Watanabe Dai, Minami Rumi, Sadamasu Kenji, Kondo Makiko, Mori Haruyo, Ueda Mikio, Tateyama Masao, Ueda Atsuhisa, Kato Shingo, Ito Toshihiro, Oie Masayasu, Takata Noboru, Hayashida Tsunefusa, Nagashima Mami, Matsuda Masakazu, Ibe Shiro, Ota Yasuo, Sasaki Satoru, Ishigatsubo Yoshiaki, Tanabe Yoshinari, Koga Ichiro, Kojima Yoko, Yamamoto Masahiro, Fujita Jiro, Yokomaku Yoshiyuki, Koike Takao, Shirasaka Takuma, Oka Shinichi, Sugiura Wataru

Abstract excerpt

The emergence and transmission of drug-resistant human immunodeficiency virus-1 (HIV-1) compromises antiretroviral treatment for HIV-1. Thus, testing for drug resistance is recommended at diagnosis and before initiating highly active antiretroviral treatment. We conducted an epidemiological study enrolling newly diagnosed patients between 2003 and 2008 in our nationwide surveillance network. In the 6-year study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Antiretroviral Therapy, Highly Active

Share to Data Collection

Share to Drug Resistance, Viral

Share to Homosexuality, Male

Share to Population Surveillance

Share to Reverse Transcriptase Inhibitors

Share to Sexual Behavior

Source

Open in PubMed

Identifiers

PMID: 20692295
DOI: 10.1016/j.antiviral.2010.07.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: nationwide surveillance from 2003 to 2008 in Japan.PMID 20692295Read ↗

Characteristics of Transmitted Drug-Resistant HIV-1 in Recently Infected Treatment-Naive Patients in Japan.Semantic proximity Read ↗

Drug-resistant HIV-1 prevalence in patients newly diagnosed with HIV/AIDS in Japan.Semantic proximity Read ↗

Trend of drug-resistant HIV type 1 emergence among therapy-naive patients in Nagoya, Japan: an 8-year surveillance from 1999 to 2006.Semantic proximity Read ↗

Prevalence of drug resistance-related mutations among HIV-1s in Japan.Semantic proximity Read ↗

Prevalence of Transmitted HIV drug resistance in antiretroviral treatment naïve newly diagnosed individuals in ChinaSemantic proximity Read ↗

Prevalence of transmitted drug resistance among HIV-1 treatment-naive patients in Beijing.Semantic proximity Read ↗

Changing Proportions of HIV-1 Subtypes and Transmitted Drug Resistance Among Newly Diagnosed HIV/AIDS Individuals — China, 2015 and 2018Semantic proximity Read ↗

Drug resistance mutation profiles of the drug-naïve and first-line regimen-treated HIV-1-infected population of Suzhou, China.Semantic proximity Read ↗

The HIV-1 Transmitted Drug Resistance in Newly Confirmed and ART-Naïve HIV-1-Infected MSM in Zhenjiang City, Jiangsu, China.Semantic proximity Read ↗

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.Semantic proximity Read ↗

Prevalence of drug-resistant human immunodeficiency virus type 1 in therapy-naive patients and usefulness of genotype testing.Semantic proximity Read ↗

Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.